Dr. Madala Ravikrishna

Dr Madala Ravikrishna is a distinguished Medical Oncologist with over 13 years of clinical experience. He is currently associated as a Consultant at KIMS Sunshine Hospital, Begumpet.

Prior to his current role, he has been associated with Tata Memorial Centre, Sri Venkateswara Institute of Medical Sciences, and Kurnool Medical College.

His speciality interests includes:

1. Medical Oncology
2. Solid Tumours
3. Thoracic Cancers
4. Head and Neck Cancers
5. Immunotherapy and Targeted Therapy
6. Chemotherapy for recurrent and metastatic malignancies
7. Personalised cancer care and palliative oncology

After completing his MBBS from Kurnool Medical College, Kurnool in 2013, Dr Ravikrishna pursued:

• MD in Radiotherapy from Sri Venkateswara Medical College, Tirupati in 2018
• DM in Medical Oncology from Tata Memorial Hospital, Mumbai in 2022

Dr Ravikrishna has made notable contributions to oncology research with multiple peer-reviewed papers, including:

• Checkpoint Inhibitor Accessibility in 15,000+ Indian Patients
• A Case of Primary Central Nervous System Lymphoma Mimicking a Demyelinating Disorder From Steroids to Stem Cell Transplant
• Retrospective analysis of checkpoint inhibitor accessibility for thoracic and head and neck cancers in a tertiary centre in India
• Real-world data of use of Nivolumab in platinum refractory head and neck cancers

He has actively participated in national and international academic forums through paper and poster presentations, including:

• Oral presentation at ASCO Annual Meeting 2022, Chicago on checkpoint inhibitor accessibility in over 15,000 Indian patients
• Oral presentation at ASCO Annual Meeting 2023, Chicago on second-line palliative chemotherapy in recurrent metastatic head and neck malignancies
• Oral paper presentation at International Cancer Congress 2016, Nagpur on dosimetric comparison of deep inspiration breath-hold versus free-breathing in left breast carcinoma patients
• Poster presentation on malignant acrospiroma of the chest wall at AROICON 2015, King George’s Medical University, Lucknow

His academic work also includes theses on:

• Dosimetric comparison of deep inspiration breath-hold with active breathing coordinator versus free-breathing in carcinoma left breast patients receiving adjuvant radiotherapy
• Demographics, pattern of care, outcome analysis, and prognostic markers of skin and soft tissue tumours across extremity and non-extremity sites

He is fluent in English, Hindi, and Telugu, enabling effective communication with patients from varied backgrounds.

Call us at 8069923891 to know about the contact number, OPD timings, and consultation fee of Dr Madala Ravikrishna. For priority appointments and a hassle-free experience, connect with the medical experts of HexaHealth.